Sreeja Karathedath

Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2

Sreeja Karathedath, Bharathi M. Rajamani, Syed Mohammed Musheer Aalam et al. · PLoS ONE · 2017 · 83 citations · Full text

Pharmacotherapy, Pharmacological Inhibition, Cancer Biology +17

RNA Expression of Genes Involved in Cytarabine Metabolism and Transport Predicts Cytarabine Response in Acute Myeloid Leukemia

Ajay Abraham, Savitha Varatharajan, Sreeja Karathedath et al. · Pharmacogenomics · 2015 · 44 citations · Full text

Atp-Binding Casette Transporter Expression in Acute Myeloid Leukemia: Association with <i>in Vitro</i> Cytotoxicity and Prognostic Markers

Savitha Varatharajan, Ajay Abraham, Sreeja Karathedath et al. · Pharmacogenomics · 2017 · 28 citations

Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia

Savitha Varatharajan, John C. Panetta, Ajay Abraham et al. · Cancer Chemotherapy and Pharmacology · 2016 · 21 citations · Full text

Hematological Malignancy, Health Sciences, Medicine +11

Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients

Bharathi M. Rajamani, Esther Sathya Bama Benjamin, Aby Abraham et al. · Scientific Reports · 2020 · 11 citations · Full text